Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT

Pliant Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 1.58M 9.69M 7.57M
Cost of Revenue
2.13M n/a 3.68M 3.2M
Gross Profit
-2.13M 1.58M 9.69M 7.57M
Operating Income
-228.37M -184.15M -127.2M -97.53M
Interest Income
n/a 24.08M 4.67M 272K
Pretax Income
-210.3M -161.34M -123.32M -97.26M
Net Income
-210.3M -161.34M -123.32M -97.26M
Selling & General & Admin
59.05M 57.93M 39.95M 27.56M
Research & Development
169.31M 127.8M 96.94M 77.55M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
228.37M 185.72M 136.88M 105.11M
Interest Expense
3.02M 1.27M 791K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
228.37M 185.72M 136.88M 105.11M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
60.54M 58.72M 42.02M 35.85M
Shares Outstanding (Diluted)
60.54M 58.72M 42.02M 35.85M
EPS (Basic)
-3.47 -2.75 -2.94 -2.71
EPS (Diluted)
-3.47 -2.75 -2.94 -2.71
EBITDA
-228.37M -158.23M -118.85M -95.73M
EBIT
-189.22M -160.07M -122.53M -97.26M
Depreciation & Amortization
-39.15M 1.84M 3.68M 1.53M